Attached files
Exhibit 21
Pharmaceutical Product Development, Inc., and Subsidiaries
Subsidiaries
The subsidiaries of Pharmaceutical Product Development, Inc., as of February 18, 2010, are as follows:
| Name of Subsidiary |
Jurisdiction of Incorporation | |||
| 1. |
Applied Bioscience International, LLC | Delaware | ||
| 2. |
PPD Global Central Labs, LLC | Kentucky | ||
| 3. |
PPD Preclinical, LLC (Formerly PRC, LLC) | North Carolina | ||
| 4. |
PPD Aeronautics, LLC | North Carolina | ||
| 5. |
PPD Virtual, Inc. | North Carolina | ||
| 6. |
APBI Finance Corporation | Delaware | ||
| 7. |
APBI Holdings, LLC | North Carolina | ||
| 8. |
Development Partners, LLC | Delaware | ||
| 9. |
PPD GP, LLC | Delaware | ||
| 10. |
PPD Holdings, LLC | Delaware | ||
| 11. |
PPD UK Holdings Ltd | United Kingdom | ||
| 12. |
Genupro, Inc. | North Carolina | ||
| 13. |
PPD Development, LP | Texas | ||
| 14. |
ATP, LLC | North Carolina | ||
| 15. |
Pharmaco Investments, Inc. | Delaware | ||
| 16. |
PPD International Holdings, Inc. | Delaware | ||
| 17. |
PPD France SNC | France | ||
| 18. |
PPD Scandinavia AB | Sweden | ||
| 19. |
Pharmaceutical Product Development Spain SL | Spain | ||
| 20. |
PPD do Brasil-Suporte a Pesquisa Clinica Ltda. | Brazil | ||
| 21. |
PPD Argentina, S.A. | Argentina | ||
| 22. |
PPD International Holdings, Inc. y Compania Limitada | Chile | ||
| 23. |
Pharmaceutical Product Development South Africa (Pty) Ltd | South Africa | ||
| 24. |
PPD Canada, Ltd. | Canada | ||
| 25. |
PPD Australia Pty Ltd | Australia | ||
| 26. |
PPD International Holdings GmbH | Germany | ||
| 27. |
PPD Germany GmbH | Germany | ||
| 28. |
PPD Poland Sp. Z o.o. | Poland | ||
| 29. |
PPD Czech Republic s.r.o. | Czech Republic | ||
| 30. |
PPD Germany GmbH & Co KG | Germany | ||
| 31. |
PPD Hungary Research & Development Limited | Hungary | ||
| 32. |
PPD Italy S.r.l. | Italy | ||
| 33. |
PPD Mexico, S.A. de C.V. | Mexico | ||
| 34. |
PPD Development (Thailand) Co., Ltd | Thailand | ||
| 35. |
PPD Japan K.K. | Japan | ||
| 36. |
PPD Global, Ltd | United Kingdom | ||
| 37. |
Clinical Technology Centre (International) Ltd | United Kingdom | ||
| 38. |
Cambridge Applied Nutrition Toxicology & Biosciences Ltd | United Kingdom | ||
| 39. |
Clinical Science Research International Ltd | United Kingdom | ||
| 40. |
Leicester Clinical Research Centre Ltd | United Kingdom | ||
| 41. |
Chelmsford Clinical Trials Unit Ltd | United Kingdom | ||
| 42. |
Gabbay Ltd | United Kingdom | ||
| 43. |
Data Analysis & Research (DAR) Ltd | Scotland |
1
| 44. |
PPD Global Central Labs BVBA | Belgium | ||
| 45. |
PPD Development (S) Pte Limited | Singapore | ||
| 46. |
PPD Development (HK) Limited | Hong Kong | ||
| 47. |
PPD (Netherlands) BV | Netherlands | ||
| 48. |
PPD Pharmaceutical Development India Private Limited | India | ||
| 49. |
River Ventures, LLC | North Carolina | ||
| 50. |
PPD Slovak Republic s.r.o. | Slovak Republic | ||
| 51. |
PPD Peru S.A.C. | Peru | ||
| 52. |
PPD Vaccines and Biologics, LLC | Pennsylvania | ||
| 53. |
PPD Pharmaceutical Development (Beijing) Co., Ltd | China | ||
| 54. |
Greenbird Limited | Cyprus | ||
| 55. |
PPD Development Ireland Ltd | Ireland | ||
| 56. |
Limited Liability Company PPD Development (Smolensk) | Russia | ||
| 57. |
PPD Global Central Labs (S) Pte. Ltd. | Singapore | ||
| 58. |
Limited Liability Company Contract Research Organization Innopharm – Ukraine | Ukraine | ||
| 59. |
PPD Dermatology, Inc. | Delaware | ||
| 60. |
PPD Therapeutics, Inc. | Delaware | ||
| 61. |
AbC.R.O., Inc. | Virginia | ||
| 62. |
PPD BULGARIA EOOD | Bulgaria | ||
| 63. |
BioDuro, LLC | Delaware | ||
| 64. |
BioDuro (Mauritius) | Mauritius | ||
| 65. |
BIODURO (BAONUO) BEIJING TECHNOLOGY CO., LTD. | Beijing, China | ||
| 66. |
Excel Pharmastudies, Inc. | Cayman | ||
| 67. |
Excel (Beijing) Medical Technology Co., LTD. | Beijing, China | ||
| 68. |
EXCEL PHARMASTUDIES TAIZHOU BIOMETRICS, INC. | Taizhou, China | ||
| 69. |
EXCEL PHARMASTUDIES TAIZHOU VACCINE, INC. | Taizhou, China | ||
| 70. |
Excel Pharmastudies (US), Inc. | California | ||
| 71. |
PPD CT Investments LLP | United Kingdom | ||
| 72. |
ABC.R.O. Bulgaria EAD | Bulgaria | ||
| 73. |
ABC.R.O. Romania S.R.L. | Romania | ||
| 74. |
AbC.R.O. d.o.o. | Croatia | ||
| 75. |
AbC.R.O. Poland Sp. Z o.o. | Poland | ||
| 76. |
Limited Liability Company ABC.R.O. | Russia |
2
Subsidiaries 1, 2, 3, 5, 52, 59, and 60 are wholly-owned subsidiaries of Pharmaceutical Product Development, Inc.
Subsidiaries 9 and 10 are wholly-owned subsidiaries of Subsidiary 1.
Subsidiary 12 is a wholly-owned subsidiary of Subsidiary 5.
Subsidiary 13 is owned 99.9% by Subsidiary 10 and 0.1% by Subsidiary 9.
Subsidiaries 4, 6, 7, 14, 15, 16, and 49 are wholly-owned subsidiaries of Subsidiary 13.
Subsidiaries 8, 18, 23, 24, 25, 26, 32, 35, and 61 are wholly-owned subsidiaries of Subsidiary 16.
Subsidiary 17 is owned 99.9999% by Subsidiary 16 and 0.001% by Subsidiary 1.
Subsidiary 19 is owned 99.231 % by Subsidiary 16 and 0.769% by Subsidiary 13.
Subsidiary 20 is owned 99.99% by Subsidiary 16 and 0.01% by Pharmaceutical Product Development, Inc.
Subsidiary 21 is owned 95% by Subsidiary 16 and 5% by Subsidiary 1.
Subsidiary 22 is owned 99% by Subsidiary 16 and 1% by Subsidiary 1.
Subsidiaries 27 and 28 are wholly-owned subsidiaries of Subsidiary 26.
Subsidiary 29 is owned 97.78% by Subsidiary 26 and 2.22% by Subsidiary 16.
Subsidiary 30 is owned 72% by Subsidiary 26 and 28% by Subsidiary 27.
Subsidiary 31 is owned 96.67% by Subsidiary 26 and 3.33% by Subsidiary 16.
Subsidiary 33 is owned 99.99% by Subsidiary 16 and 0.01% by Subsidiary 13.
Subsidiary 34 is owned 99.99% by Subsidiary 16 and 1 share is held by each of Subsidiary 7, Subsidiary 11, Subsidiary 36, Subsidiary 45, Subsidiary 46, and 1 individual.
Subsidiaries 36, 40, 41, 42, 43, 45, 47, 55, 57, 62, 63, and 66 are wholly-owned subsidiaries of Subsidiary 11.
Subsidiary 37 is owned 99% by Subsidiary 36 and 1% by Subsidiary 11.
Subsidiary 38 is owned 50% by Subsidiary 11 and 50% by Subsidiary 36.
Subsidiary 39 is a wholly-owned subsidiary of Subsidiary 36.
Subsidiary 44 is 99.9% owned by Subsidiary 11 and .1% by Subsidiary 36.
Subsidiary 46 is 50% owned by Subsidiary 45 and 50% by Subsidiary 1.
Subsidiary 48 is owned 99.99% by Subsidiary 11 and 0.01% by Subsidiary 36.
Subsidiary 50 is owned 85% by Subsidiary 11 and 15% by Subsidiary 36.
Subsidiary 51 is owned 99% by Subsidiary 16 and 1% by Subsidiary 1.
Subsidiary 53 is a wholly-owned subsidiary of Subsidiary 45.
Subsidiary 54 is owned 99.95% by Subsidiary 11 and 0.05% by Subsidiary 47.
Subsidiary 56 is a wholly-owned subsidiary of Subsidiary 54.
Subsidiary 58 is a wholly-owned subsidiary of Subsidiary 56.
Subsidiary 11 is 99.6% owned by Subsidiary 16 and 0.4% by Subsidiary 61.
Subsidiary 64 is wholly-owned subsidiary of Subsidiary 63.
Subsidiary 65 is wholly-owned subsidiary of Subsidiary 64.
Subsidiary 67 and 70 is wholly-owned subsidiary of Subsidiary 66.
Subsidiary 68 is 85% owned by Subsidiary 67 and 15% by a Chinese entity.
Subsidiary 69 is 80% owned by Subsidiary 67, 5% by Subsidiary 68, and 15% by a Chinese entity.
Subsidiary 71 is 80% owned by Subsidiary 6 and 20% owned by Subsidiary 16.
Subsidiaries 72, 74, and 75 are wholly-owned subsidiaries of Subsidiary 61.
Subsidiary 73 is 99.3% owned by Subsidiary 61 and 0.7% owned by Subsidiary 62.
Subsidiary 76 is 75% owned by Subsidiary 62 and 25% owned by Subsidiary 61.
3